Fed. Circ. Partially Revives AstraZeneca Asthma Drug IP Row

The Federal Circuit on Wednesday reversed a lower court’s non-infringement ruling on one patent in an intellectual property dispute over AstraZeneca PLC’s Pulmicort Respules pediatric asthma medication but upheld the court’s finding ...read more

  • Tags: